Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

The McGill Geriatric Lithium-Induced Diabetes Insipidus Clinical Study (McGLIDICS)

FY 2011-12

Summary
Lithium is an important medication in the treatment of mood disorders (bipolar disorder and depression). Diabetes Insipidus (DI) is a condition associated with lithium use that occurs in 12-19% of adults (18-65 years old). In DI, patients urinate excessively, which can be socially embarrassing, disrupt sleep, increase the risk of falling, and lead to discontinuing lithium, which can worsen a patient's mood disorder. DI can also lead to life-threatening increases in blood sodium levels, which can cause extreme fatigue, seizures, and even death, especially in the elderly. Despite DI's impact on the health of older people, it remains unknown how common symptoms of DI and how common elevated blood sodium levels are in geriatric patients (>65 years old). There are very few studies that have compared adults and the elderly for DI. Also, how common other medical side effects of lithium use are (e.g. kidney failure), remains unknown in geriatric patients. We will conduct a study of geriatric patients, aged 65 and older, who use lithium. This will be done in clinics at McGill and University of Toronto. Patients will be asked questions about DI (e.g. "do you urinate at night?") and will be asked to provide a blood and urine test. The questionnaire and tests will screen for symptoms and laboratory results (e.g. high blood sodium) related to DI and other side effects of lithium. We will collect similar information from adults (18-65) to make comparisons between the two groups to determine if DI is more common in geriatric patients. We are aiming to study 70 geriatric and 70 adult patients. This study will help us determine how common DI symptoms, high blood sodium levels and other side effects of lithium (e.g. kidney failure) are in elderly patients. This information can raise awareness of the impact of DI and other side effects of lithium use. In doing so, this research can inform safe prescribing and monitoring of lithium use in geriatric patients.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
252429
Name
Rej Soham
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
The McGill Geriatric Lithium-Induced Diabetes Insipidus Clinical Study (McGLIDICS)
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Diabetes Insipidus; Epidemiology; Geriatric; Hypernatremia; Lithium; Psychopharmacology; Renal; Side Effects
Abstract
Lithium is an important medication in the treatment of mood disorders (bipolar disorder and depression). Diabetes Insipidus (DI) is a condition associated with lithium use that occurs in 12-19% of adults (18-65 years old). In DI, patients urinate excessively, which can be socially embarrassing, disrupt sleep, increase the risk of falling, and lead to discontinuing lithium, which can worsen a patient's mood disorder. DI can also lead to life-threatening increases in blood sodium levels, which can cause extreme fatigue, seizures, and even death, especially in the elderly. Despite DI's impact on the health of older people, it remains unknown how common symptoms of DI and how common elevated blood sodium levels are in geriatric patients (>65 years old). There are very few studies that have compared adults and the elderly for DI. Also, how common other medical side effects of lithium use are (e.g. kidney failure), remains unknown in geriatric patients. We will conduct a study of geriatric patients, aged 65 and older, who use lithium. This will be done in clinics at McGill and University of Toronto. Patients will be asked questions about DI (e.g. "do you urinate at night?") and will be asked to provide a blood and urine test. The questionnaire and tests will screen for symptoms and laboratory results (e.g. high blood sodium) related to DI and other side effects of lithium. We will collect similar information from adults (18-65) to make comparisons between the two groups to determine if DI is more common in geriatric patients. We are aiming to study 70 geriatric and 70 adult patients. This study will help us determine how common DI symptoms, high blood sodium levels and other side effects of lithium (e.g. kidney failure) are in elderly patients. This information can raise awareness of the impact of DI and other side effects of lithium use. In doing so, this research can inform safe prescribing and monitoring of lithium use in geriatric patients.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rej, Soham
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~